The Women’s Tennis Association (WTA) announced it will mandate genetic sex testing for all players wishing to compete in tour events. This new policy will require all athletes to undergo testing to confirm their sex. The WTA has not yet released specific details regarding the testing process or the criteria for disqualification. Advocates suggest the measure aims to ensure fair competition and address concerns related to gender identity in sports. Critics raise privacy concerns and question the necessity of such invasive testing. The policy’s implementation date and potential challenges are yet to be announced, but it marks a significant shift in regulations within professional women’s tennis.